Timothy C Wentworth Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days, 16 hours ago
Timothy C Wentworth has an estimated net worth of at least $14.1 million*, as of April 23, 2025. They own 1.3 million shares of WBA stock. They have sold 0 shares of WBA stock since 2021, for an estimated $-242,220.
Timothy C Wentworth $WBA SEC Form 4 Insider Trading
Timothy C Wentworth has filed a total of 1 insider trades in $WBA since 2021. Their most recent trade was a purchase of 10,000 shares, made on Jan 05, 2024. Their largest trade was a purchase of 10,000 shares, made on Jan 05, 2024. We estimate that they now own 1.3 million shares of $WBA, worth an estimated $14.3 million.
Insider Trading at $WBA
There have been a total of 11 insider trades reported at $WBA since 2021, with 38,628 shares purchased and 45,807 shares sold. The most active insider traders in $WBA stock have been John Patrick Driscoll, Kevin M. Ban, and Manmohan Mahajan. The most recent trade was a purchase of 3,000 shares reported by Inderpal S Bhandari (None), made on Apr 11, 2024.
History of Insider Stock Trades by Timothy C Wentworth
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Purchase | 10,000 | Jan 05, 2024 | Jan. 8, 2024, 8:29 a.m. |
$WBA Executives and Stock Owners with Insider Trades
-
John Patrick Driscoll, EVP, Pres. U.S. Healthcare
-
Kevin M. Ban, EVP, Chief Medical Officer
-
Manmohan Mahajan, EVP and Global CFO
-
Rosalind G Brewer, CEO
-
Richard P. Gates, SVP, Chief Pharmacy Officer
-
Timothy C Wentworth, Chief Executive Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.